Tim Sharpington News Today

Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial collaboration with MSD (Merck Co., Inc., Rahway

Faecal transplants might help treat illnesses such as arthritis, diabetes and cancer. And one day it could be as simple as taking a pill made from a stranger’s poo. Our writer volunteers a sample

Co-founder and CEO Mike Romanos steps down after six years to take up role of Associate Dean of Enterprise in the Faculty of Medicine at Imperial College Tim Sharpington, Microbiotica COO